Subscribe
Call Us: 02380 97 07 33

Archive for 2015

Another pre-reg project presented…

Another pre-reg project presented…

by Kazeem Olalekan In our next installment of the pre-registration project, Prabsimranjeet Rathaur describes his audit project on evaluating the use of patient controlled analgesia (PCA) on surgical and orthopaedic wards. …this may represent opportunity to review the current guideline with the hope of gaining consensus across all prescribers….I […]

Read more

A pre-registration project – another first for bookapharmacist

A pre-registration project – another first for bookapharmacist

by Kazeem Olalekan We are always looking at ways to encourage different aspects of quality practice at bookapharmacist.com. To fulfill our audit dissemination agenda, we are encouraging pre-registrations pharmacists – past and present to discuss their audit/pre-reg project in a short time frame.  Our first volunteer, Tomisin […]

Read more

Improving Productivity & Performance

Improving Productivity & Performance

by Kazeem Olalekan   Economists are a funny lot! They are obsessed with the two P’s of the economy: Performance & Productivity. Productivity is commonly defined as a ratio between output volume and the volume of input (1). As we know from our elementary physics – that […]

Read more

World Aids Day 2015 #RETHINKHIV

World Aids Day 2015 #RETHINKHIV

by Kazeem Olalekan Today marks another landmark in the battle to combat and defeat the HIV. The theme for World Aids Day 2015 is “Getting to zero – ending AIDS by 2030” (link). This is an aspiration we all share especially with 37 million people living with […]

Read more

Something to shout about….

Something to shout about….

by Kazeem Olalekan The latest Intensive Care National Audit and Research Centre (ICNARC) report showed the general intensive care unit (GICU) at Southampton General Hospital had the lowest number of deaths over a three-month period. Now that is something to be really proud of….Well done to the […]

Read more

Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

by Kazeem Olalekan MRPharmS The Medicines and Healthcare products Regulatory Agency has just issued a Class 4 Drug Safety Alert for Wockhardt UK Ltd – Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection. Alert details Drug alert number EL (14)A/09 in connection with the […]

Read more

More Respiration than Perspiration

More Respiration than Perspiration

by Kazeem Olalekan When in March last year, Kazeem met Adel, it was bound to be another insightful interview and meeting of old mates. Adel featured in my first book: The Doctrine of Universal Truths. From one ‘wacky’ idea to the next, we stumbled along and then […]

Read more

A practical point – Picato: ingenol mebutate

A practical point – Picato: ingenol mebutate

by Kazeem Olalekan MRPharmS Pharmacognosy is the branch of knowledge concerned with medicinal drugs obtained from plants or other natural sources. This has been critical to drug development and exemplified by the recent ward of the Nobel prize for medicines to the Chinese scientist Youyou Tu (a […]

Read more

Pharmacy: Third Largest Health Profession in the UK

Pharmacy: Third Largest Health Profession in the UK

By Kazeem Olalekan With pressure on services across the NHS, it is time to really look at making better use of the third largest health professionals in the UK – The Pharmacists. Watch the video below produced by the Royal Pharmaceutical Society and your pharmacist will see […]

Read more

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.